NADIMPALLI RAJU: Open Payments
NPI 1700834827 · DETROIT, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$329 in 6 payments from 4 companies in 2025. Trend: 2023 $22 · 2024 $90 · 2025 $329
Food & beverage: $329
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 1 | $124 |
| E.R. Squibb & Sons, L.L.C. | 1 | $121 |
| Vanda Pharmaceuticals Inc. | 2 | $49 |
| Janssen Pharmaceuticals, Inc | 2 | $35 |
Products named: INGREZZA, COBENFY, FANAPT, INVEGA SUSTENNA.
Industry payments across MI — which companies pay providers there.
